New stem cell filter could reduce transplant complications for vulnerable patients
NCT ID NCT06731036
First seen Feb 23, 2026 · Last updated May 19, 2026 · Updated 15 times
Summary
This expanded access program offers a special stem cell processing technique (CD34+ selection) to patients with severe combined immune deficiency, Fanconi anemia, dyskeratosis congenita, or sickle cell disease who are receiving a stem cell transplant. The method removes certain immune cells from the donated stem cells to lower the risk of graft-versus-host disease, a serious complication. The goal is to make transplants safer for these patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.